Prognostic Role of Histological Tumor Regression in Patients Receiving Neoadjuvant Chemotherapy for High-Grade Serous Tubo-ovarian CarcinomaEdwina Coghlan, Paul A. Cohen, Stuart Salfinger et al.|International Journal of Gynecological Cancer|2017Cited by 51
Risk of persistent and recurrent cervical neoplasia following incidentally detected adenocarcinoma in situAime Munro, Paul A. Cohen, Jim Codde et al.|American Journal of Obstetrics and Gynecology|2016Cited by 23
Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological marginsAime Munro, Paul A. Cohen, Jim Codde et al.|Acta Obstetricia Et Gynecologica Scandinavica|2017Cited by 12
Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and cold knife cone biopsyPaul A. Cohen, C. David Wrede, Yee Leung et al.|Gynecologic Oncology|2020Cited by 9
<u>Ex</u>cisional Treatment&nbsp; <u>C</u>omparison For&nbsp; <u>I</u>n&nbsp; <u>S</u>itu&nbsp; <u>E</u>ndocervical Adenocarcinoma (EXCISE): A Phase 2 Pilot Randomised Controlled Trial to Compare Histopathological Margins Status, Specimen Size and Fragmentation after Loop Electrosurgical Excision Procedure and Cold Knife Cone BiopsyPaul A. Cohen, C. David Wrede, Yee Leung et al.|SSRN Electronic Journal|2020Cited by 0